At diagnosis, approximately 40% of patients had tumors within HAR, and 33.7% experienced recurrent tumors near the hippocampus.

Why brain cancer is often resistant to immunotherapy Date: February 26, 2025 Source: Broad Institute of MIT and Harvard Summary: New findings could help make immunotherapies for brain cancer more ...

Medical researchers in Japan have discovered a way to predict a potentially life-threatening side effect of cancer immunotherapy before it occurs.

There are over 100 different types of brain tumours. Tumours can start in any part of the brain or spinal cord. They are usually named after the type of cell they develop from. Read about the ...

REDMOND, WA, UNITED STATES, March 3, 2025 /EINPresswire / -- The End Brain Cancer Initiative (EBCI) is currently seeking Primary Central Nervous System Lymphoma (PCNSL) patients and care partners ...